CIRCULAR GENOMICS
Circular Genomics is a biotechnology and genomics company that develops RNA-based diagnostic and therapeutic assays to facilitate the treatment of psychiatric and neurological diseases. The company was founded in 2021 and is headquartered in Albuquerque, New Mexico.
CIRCULAR GENOMICS
Industry:
Biotechnology Health Care Therapeutics Wellness
Founded:
2021-01-01
Address:
Albuquerque, New Mexico, United States
Country:
United States
Website Url:
http://www.circulargenomics.com
Total Employee:
1+
Status:
Active
Total Funding:
4.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Euro Google Apps For Business Google GStatic Google Static Content Google Cloud
Current Advisors List
Board_member
Current Employees Featured
Alexander Hafez Co-Founder, President & CEO @ Circular Genomics
Co-Founder, President & CEO
Founder
Investors List
Mountain Group Capital
Mountain Group Capital investment in Seed Round - Circular Genomics
Cottonwood Technology Fund
Cottonwood Technology Fund investment in Seed Round - Circular Genomics
Tramway Venture Partners
Tramway Venture Partners investment in Seed Round - Circular Genomics
Official Site Inspections
http://www.circulargenomics.com
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.107
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Circular Genomics"
Circular Genomics | Precision Psychiatry
Circular Genomics is a pioneering precision psychiatric and neurologic medicine biotechnology company, using advanced technology and proprietary data to uncover insights for …See details»
Circular Genomics - LinkedIn
Circular Genomics is the global leader in the use of circular RNA as a novel biomarker to power precision medicine to improve the diagnosis and treatment of neurological and psychiatric conditions ...See details»
Circular Genomics - Crunchbase Company Profile & Funding
Circular Genomics may be growing as it successfully closed a funding round in 2023, securing $1.5 million. This influx of capital suggests investor confidence and the potential for the …See details»
Careers - Circular Genomics
Please email your resume or CV to info@circulargenomics.com. View job listings. 10935 Alexandria Way, Suite 201 San Diego, CA 92037 . info@circulargenomics.com ...See details»
Circular Genomics Company Profile | Management and Employees …
Company Name. Circular Genomics. Main Industry. Research & Development, Business Services. Website. www.circulargenomics.comSee details»
Circular Genomics - VentureRadar
Website: https://www.circulargenomics.com/ Leverages circular RNA biomarkers to transform precision psychiatry, predicting SSRI responses, diagnosing brain disorders ...See details»
Circular Genomics, Inc. - PrivCo
Circular Genomics, Inc. is a privately-held biotechnology and genomics company that develops RNA-based diagnostic and therapeutic assays to facilitate the treatment of psychiatric and …See details»
Circular Genomics - PitchBook
Circular Genomics General Information Description. Developer of RNA-based diagnostic assay designed for the treatment of depressive disorders. The company's circular RNA diagnostics allows for an evidence-based approach to …See details»
Circular Genomics - TechCrunch
Www.circulargenomics.com. Founders. Alexander Hafez. Founder. Highlights as of Jan 1, 2025. $12.8M. Money Raised; Profile Updates. Have updates? Send them our way! You know your company best! If ...See details»
Precision Medicine in Mental Health Company, Circular …
Apr 27, 2023 For more information, please visit www.circulargenomics.com. SOURCE Circular Genomics. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media ...See details»
Circular Genomics | Precision Psychiatry
Nov 5, 2024 Circular Genomics is advancing precision medicine through our novel circular RNA approach for the accurate diagnosis and treatment of psychiatric and neurological disorders.See details»
Local Startup Circular Genomics Closes $8.3M Investment Round
Jan 26, 2024 Circular Genomics, a local startup commercializing technology developed at the University of New Mexico, has closed on an $8.3 million Series A investment round led by …See details»
Local Bioscience Startup Circular Genomics Raises $1.5M
Mar 28, 2023 Circular Genomics has recently raised $1.5 million to further expand its research and development operations and grow the company’s team. This is part of a $3.2 million …See details»
Local Startup Circular Genomics Closes $4.5M Series Seed …
Jan 8, 2022 Local startup Circular Genomics recently closed on a $4.5M series seed investment round for their innovative research on circular RNA to target effective treatment options for …See details»
Circular Genomics | Circular RNA
Unlike DNA pharmacogenetic testing, which reports the static disposition of genetic inheritance to metabolize a drug, circular RNAs reflect an individual's current biological state, providing real …See details»
Circular Genomics Closes $4.5M Series Seed Investment
Alex Hafez – alex@circulargenomics.com; +1 505 677-0512 Dave Blivin – dave@cottonwood.vc; +1 505 412-8537 Waneta Tuttle – wtuttle@tramwayventures.com; +1 505 710-1463 . Recent …See details»
Circular Genomics Announces Two Significant Steps Forward
Jul 11, 2023 Contact Data Jamie Dickerman Circular Genomics 505-720-2195 jdickerman@sunny505.comSee details»
Circular Genomics Joins Lilly Gateway Labs in San Diego to …
Mar 17, 2025 Circular Genomics' move to the Lilly Gateway Labs community will enhance scientific collaboration and innovation to foster the development of its Alzheimer's disease …See details»
DNA organization offers clues for advancing stem cell therapy
4 days ago DNA organization offers clues for advancing stem cell therapy. by Iqbal Pittalwala, University of California - Riverside. Stem cells (shown as small balls) can be imagined to roll …See details»
Circular Genomics Strengthens Scientific Advisory Board with …
Mar 19, 2025 Phyllis Barkman Ferrell, MBA, DrPH, brings decades of experience in neurological conditions with a focus on Alzheimer's diseaseSAN DIEGO, March 19, 2025 - Circular …See details»